In summary, glioblastoma subgroups with increased Δ133p53β mRNA were located in cells similar to those with CCL2 expression and an increased immunosuppressive phenotype with increased CSF1R and PDL1‐positive cells. This evidence concerns the gene CCL2 and glioblastoma.